ADCC	Antibody-dependent cellular cytotoxicity
APCs	Antigen presenting cells
CAR-T	Chimeric antigen receptor
CRC	Colorectal cancer
CRT	Calretikuin
CSF	Colony Stimulating Factor
CTL	Cytotoxic T lymphocyte
CTLA-4	Cytotoxic T lymphocyte antigen-4
DC	Dendritic cell
EGFR	Epidermal growth factor receptor
EM	Exosome mimetic
EMA	European Medicines Agency
FDA	Food and Drug Administration
HER-2	Human epidermal growth factor receptor 2
ICI, ICB	Immune checkpoint inhibitor or blocker
IDO	Indoleamine 2,3-dioxygenase
IL	Interleukin
IFN	Interferon
LNP	Lipid nanoparticles
LPS	Lipopolysaccharide
MDSC	Myeloid-derived suppressor cell
MHC	Major histocompatibility complex
MRI	Magnetic resonance imaging
MSNP	Mesoporous silica nanoparticles
NK	Natural Killer
NSCLC	Non-small cell lung cancer
OVA	Ovalbumin
PBL	Peripheral blood lymphocytes
PDAC	Pancreatic ductal adenocarcinoma
PD-1	Programmed death-1
PD-L1/2	Programmed death-ligand 1 and 2
PEG	Polyethylene glycol
PEI	Polyethyleneimine
PLA	Polylactic acid
PLGA	Poly (lactic-co-glycolic acid)
TAAs	Tumor-associated antigens
TAMs	Tumor-associated macrophages
TCR	T cell receptor
Tc	Cytotoxic T cells
Th	T helper cells
Tregs	Regulator T cells
TILs	Tumor-infiltrated lymphocytes
TLRs	Toll-like receptors
TNF	Tumor necrose factors
TSA	Tumor specific antigen
VEGFR	Vascular endothelial growth factor receptor